38.78 USD
▲+0.36+8.93%
盘后 36.00 +1.12%
2026-08-03
市值
$2.26B
市盈率
12.55
EPS
2.48
股息率
—
52 周区间
25.52 – 40.87
成交量
1.99M
Beta
0.91
目标价
45.50
52W 低 25.5252W 高 40.87
价格走势
公司简介
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that is in Phase 3 clinical trial for the treatment of Prader-Willi Syndrome (PWS); in Phase 2 clinical trial to treat Myotonic Dystrophy (DM1); and is in P...